NICOLE BALAGULA

Sales & Quantitative Achievements

Q4 2021 Regional Rank 14

Q4 2022 Regional Rank 227/303, 42 regional rank

Q1 2023 Regional Rank 46 National Rank 196 out of 298

Q2 2023 Regional Rank 36 National Rank 178 out of 298

Q3 2023 Regional Rank 32 National Rank 179 out of 298

Q4 2023 Regional Rank 11 National Rank 97 out of 298

Q1 2024 Regional Rank 48 National Rank 257 out of 300

Q2 2024 Regional Rank 52 National Rank 285 out of 300

Q3 2024 Regional Rank 54 National Rank 261 out of 299

Q4 2024 Regional Rank 47 National Rank 230 out of 299

Q1 2025 Regional Rank 11 National Rank 33 out of 300

• Leader board for Q1 SPIFF & Q4 SPIFF in 2024 growing the Volume and Share for both products significantly
• Regional top performer for increasing Creon NBRX % in 13 weeks, 17.4%.
• Won SPIFF contests for CREON, LINZESS, and VIBERZI by increasing new-to-brand RXs (NBRx and NRx) % volume in Q4 2022.
• Leader board for the current DRIVE 25 SPIFF leaderboard.
• Won the Mindset Award.

Sales and Qualitative Achievements

• Achieved sales of Creon, PERT for adult and pediatric exocrine pancreatic insufficiency.
• Generated revenue through Linzess sales for IBS-C/CIC treatment.
• Drove Viberzi sales targeted at IBS-D patients.
• Promoted Creon, Linzess, and Viberzi to primary care physicians and specialists including gastroenterologists, endocrinologists, and oncologists.
• Conducted comprehensive pharmacy outreach to ensure medication access for patients.
• Facilitated successful onboarding processes for new hires as district trainer. ·
• Guest Trainer for Creon IFTC April 2024
• Developed strong relationships with office staff through total office engagement strategies.
• Led initiatives during ACG conferences to strengthen professional connections.
• Launched Creon Complete program, providing essential resources for patient support.
• Participated in multiple training workshops focusing on learnings and development.
• Adapted sales strategies during pandemic, successfully completing first virtual training class.
• ·Conducted regional projects as a Regional Advisory Board Member.
• Served as district lead for Value-Added Team with Regional Business Executive.

Company Overview: AmGen GenMed Contract

Sales and Quantitative Achievements

• Prolia “Grow New to Break Through” Contest – Share growth over baseline.
• Repatha “EMBRACE THE RACE” Contest – NRx Share over Baseline | Ranked: National Award 5th place out of 87 districts
• Repatha “BEND THE CURVE” Contest – NBRx Growth from Target Prescribers over Baseline | Ranked: 42 out of 84
• Consistently maintain the highest Repatha NRx and Units Volume in the Northeast Region and delivered on reach goals
• Average NRx per week: Q3 2018: 18.32 | Q4 2018: 19.61 | Q1 2019: 24.32
• Average Units per week: Q3 2018: 158.32 | Q4 2018: 158.93 | Q1 2019: 173.93
• Consistently grew Prolia Volume semester over semester in terms of unit growth
• Q3 2018 - 92.3% | 298 SGA RANK
• Q4 2018-109.8% | 51 SGA RANK
• Q1 2019 98.9% 285 SGA RANK
• Q2 2019 94.3% 289 SGA RAN
• Q3 2019 93.3% 284 SGA RANK
• Q4 2019 112.4% 111 SGA RANK
• Grew Evenity Sales from April Launch sold 14 syringes volume ranked 67 out of 124
• Chairman’s Circle Rank 152 out of 417
• Organize Speaker Programs completed 6 programs, 5 Prolia Programs, 1 Repatha Program, 2 Evenity Programs

Sales and Qualitative Achievements

• Sold Repatha, PCSK9 inhibitor to prevent Cardiovascular Events in adults with cardiovascular disease.
• Promoted Prolia, Repatha, Evenity to Primary Care Physicians, Cardiologists, and Endocrinologists
• Sold Prolia for multiple Osteoporosis indications in both specialty pharmacy and buy and bill market, knowledge of managed care specialty pharmacy
• Created and foster relationships with all stakeholders in a prescriber’s office
• Launched a product successfully in Osteoporosis market using a whole account approach to ensure patients received their medication
• Sold Evenity indicated for the treatment of Osteoporosis in both specialty pharmacy and buy and bill market, knowledge of managed care specialty pharmacy.
• Opened Buy and Bill Accounts
• District Culture Lead, worked closely with team members to ensure Amgen Values
• Member of WE2 Women Empowerment
• AmGen GenMed Contract

• Translated medical information for Russian patients and pharmacists to ensure clarity.
• Conducted profile reviews to educate patients on medical history and prescription indications.
• Served as liaison between patients and prescribers to address concerns effectively.
• Prepared and dispensed prescriptions accurately to meet patient needs.
• Counseled patients on over-the-counter medications for safe usage.
• Organized Flu, Zostavax, and Pneumonia clinics to achieve store objectives.
• Trained new pharmacy technicians, enhancing team performance and service quality.